Current Report Filing (8-k)
22 June 2018 - 6:04AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant to Section 13 or 15(d)
of The Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): June 21, 2018
Foundation Medicine, Inc.
(Exact name of registrant as specified in its charter)
|
|
|
|
|
Delaware
|
|
001-36086
|
|
27-1316416
|
(State or other jurisdiction
of incorporation)
|
|
(Commission
File Number)
|
|
(I.R.S. Employer
Identification No.)
|
|
|
150 Second Street
Cambridge, MA
|
|
02141
|
(Address of principal executive offices)
|
|
(Zip Code)
|
Registrants telephone number, including area code (617)
418-2200
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form
8-K
filing is intended to simultaneously satisfy the filing obligation of
the registrant under any of the following provisions:
☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
☐
|
Soliciting material pursuant to Rule
14a-12
under the Exchange Act (17 CFR
240.14a-12)
|
☐
|
Pre-commencement
communications pursuant to Rule
14d-2(b)
under the Exchange Act (17 CFR
240.14d-2(b))
|
☐
|
Pre-commencement
communications pursuant to Rule
13e-4(c)
under the Exchange Act (17 CFR
240.13e-4(c))
|
Indicate by check mark whether the registrant is an emerging growth company as
defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or
Rule 12b-2 of
the Securities Exchange Act of 1934
(§240.12b-2
of this
chapter).
Emerging growth company ☒
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange
Act. ☒
Item 5.07
|
Submission of Matters to a Vote of Security Holders.
|
At the Annual Meeting of
Stockholders of Foundation Medicine, Inc. (the Company) held on June 21, 2018, all proposals brought before the meeting and requiring approval were approved by the requisite vote. The votes with respect to each proposal are set
forth below.
|
1.
|
Proposal 1: Election of Directors
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nominee
|
|
For
|
|
|
Withheld
|
|
|
Broker Non-Votes
|
|
Alexis Borisy
|
|
|
25,573,360
|
|
|
|
3,818,027
|
|
|
|
6,038,571
|
|
Troy Cox
|
|
|
26,693,570
|
|
|
|
2,697,817
|
|
|
|
6,038,571
|
|
Michael Dougherty
|
|
|
28,865,592
|
|
|
|
525,795
|
|
|
|
6,038,571
|
|
Sandra Horning, M.D.
|
|
|
25,930,540
|
|
|
|
3,460,847
|
|
|
|
6,038,571
|
|
Evan Jones
|
|
|
28,572,915
|
|
|
|
818,472
|
|
|
|
6,038,571
|
|
Daniel ODay
|
|
|
25,929,975
|
|
|
|
3,461,412
|
|
|
|
6,038,571
|
|
Michael Pellini, M.D.
|
|
|
25,702,195
|
|
|
|
3,689,192
|
|
|
|
6,038,571
|
|
Michael Varney, Ph.D.
|
|
|
23,133,815
|
|
|
|
6,257,572
|
|
|
|
6,038,571
|
|
Krishna Yeshwant, M.D.
|
|
|
29,003,834
|
|
|
|
387,553
|
|
|
|
6,038,571
|
|
Pursuant to the foregoing votes, the Director nominees listed above were elected to serve on the
Companys Board of Directors until the Companys 2019 Annual Meeting of Stockholders.
|
2.
|
Proposal 2:
Ratification of KPMG LLP as the Companys Independent Registered Public
Accounting Firm
|
|
|
|
|
|
For: 35,373,072
|
|
|
Against: 34,368
|
|
|
Abstain: 22,518
|
Pursuant to the foregoing votes, the appointment of KPMG LLP as the Companys independent registered
public accounting firm for the year ending December 31, 2018 was ratified and approved.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.
|
|
|
|
|
|
|
Date: June 21, 2018
|
|
|
|
FOUNDATION MEDICINE, INC.
|
|
|
|
|
|
|
|
|
By:
|
|
/s/ Robert W. Hesslein
|
|
|
|
|
|
|
Robert W. Hesslein
|
|
|
|
|
|
|
Senior Vice President and General Counsel
|
Foundation Medicine, Inc. (NASDAQ:FMI)
Historical Stock Chart
From Jun 2024 to Jul 2024
Foundation Medicine, Inc. (NASDAQ:FMI)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about Foundation Medicine, Inc. (delisted) (NASDAQ): 0 recent articles
More Foundation Medicine, Inc. News Articles